RAM
DARE icon

Riggs Asset Management’s Dare Bioscience DARE Stock Holding History

Riggs Asset Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42
Closed -$456 – 418
2023
Q2 		$456 Hold
42
– – ﹤0.01% 364
2023
Q1 		$520 Buy
42
+21
+100% +$279 ﹤0.01% 339
2022
Q4 		$208 Buy
+21
New +$235 ﹤0.01% 320

Other funds holding DARE

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Riggs Asset Management's DARE Position: Q3 2023 in Review

Riggs Asset Management sold out of Dare Bioscience (DARE) in Q3 2023, closing a stake of 42 shares — an estimated $456 sold.

Riggs Asset Management first reported a position in DARE in Q4 2022 and held it in 3 quarters. The position peaked at $520 in Q1 2023. 30 funds tracked by Wall St. Rank hold DARE as of Q3 2023.

  • Riggs Asset Management reported no remaining Dare Bioscience position as of Q3 2023 after selling out during the quarter.
  • Riggs Asset Management sold 42 Dare Bioscience shares in Q3 2023, an estimated $456.
  • Riggs Asset Management first reported a position in Dare Bioscience in Q4 2022 and held it in 3 quarters.
  • Riggs Asset Management's Dare Bioscience position peaked at $520 in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2023.

Based on Riggs Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.